Publications in collaboration with researchers from Pfizer (United States) (1)

1996

  1. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis

    Thrombosis and Haemostasis, Vol. 76, Núm. 2, pp. 195-199